Hrt Financial LP My Md Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.44 - $2.26 $21,333 - $33,481	14,815 New	14,815 $22,000
Q2 2022 Aug 12, 2022	BUY	$2.0 - $4.78 $36,288 - $86,728	18,144 New	18,144 $39,000
Q1 2022 May 16, 2022	SELL	$3.34 - $6.05 $52,942 - $95,898	-15,851 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.46 - $9.69 $86,546 - $153,596	15,851 New	15,851 $96,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.